Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83.
Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6
Klein, B., X. G. Zhang, M. Jourdan, J. Content, F. Houssiau, L. Aarden, M. Piechaczyk, and R. Bataille. 1989. Paracrine rather than autocrine regulation of myeloma cell growth and differentiation by interleukin-6. Blood 73:517.
CD40 expression in malignant plasma cells: Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line
Westendorf, J. J., G. J. Ahmann, R. J. Armitage, M. K. Spriggs, J. A. Lust, P. R. Greipp, J. A. Katzmann, and D. F. Jelinek. 1994. CD40 expression in malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J. Immunol. 152:117.
CD40 ligand triggered interleukin-6 secretion in multiple myeloma
Urashima, M., D. Chauhan, H. Uchiyama, G. J. Freeman, and K. C. Anderson. 1995. CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903.
Production of cytokines by bone marrow cells obtained from patients with multiple myeloma
Lichtenstein, A., J. Berenson, D. Norman, M. P. Chang, and A. Carlile. 1989. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. Blood 74:1266.
Role of bone marrow stromal cells in the growth of human multiple myeloma
Caligaris-Cappio, F., L. Bergui, M. G. Gregoretti, G. Gaidano, M. Gaboli, M. Schena, A. Zallone, and P. C. Marchisio. 1991. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood 77:2688.
Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma
Zhang, X. G., J. P. Gaillard, N. Robillard, Z. Y. Lu, Z. J. Gu, M. Jourdan, J. M. Boiron, R. Bataille, and B. Klein. 1994. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654.
Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion
Uchiyama, H., B. A. Barut, A. F. Mohrbacher, D. Chauhan, and K. C. Anderson. 1993. Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion. Blood 82:3712.
Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma
Ahsmann, E. J., H. M. Lokhorst, A. W. Dekker, and A. C. Bloem. 1992. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood 79:2068.
Interleukin-6 inhibits apoptosis of malignant plasma cells
Lichtenstein, A., Y. Tu, C. Fady, R. Vescio, and J. Berenson. 1995. Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell. Immunol. 162:248.
Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis
Kawano, M. M., K. Mihara, N. Huang, T. Tsujimoto, and A. Kuramoto. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487.
Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders
Hata, H., H. Matsuzaki, M. Takeya, M. Yoshida, T. Sonoki, A. Nagasaki, N. Kuribayashi, F. Kawano, and K. Takatsuki. 1995. Expression of Fas/Apo-1 (CD95) and apoptosis in tumor cells from patients with plasma cell disorders. Blood 86:1939.